AWA
CRL icon

Aaron Wealth Advisors’s Charles River Laboratories CRL Stock Holding History

Aaron Wealth Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$567K Buy
2,499
+75
+3% +$13.4K 0.03% 388
2026
Q1 		$418K Buy
2,424
+287
+13% +$53.2K 0.02% 436
2025
Q4 		$426K Sell
2,137
-732
-26% -$133K 0.02% 479
2025
Q3 		$449K Buy
+2,869
New +$456K 0.03% 436
2025
Q2 		– Sell
-1,385
Closed -$208K – 496
2025
Q1 		$208K Buy
+1,385
New +$232K 0.02% 427
2022
Q2 		– Sell
-34,360
Closed -$121K – 332
2022
Q1 		$121K Buy
+34,360
New +$10.6M ﹤0.01% 866

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Aaron Wealth Advisors's CRL Position: Q2 2026 in Review

Aaron Wealth Advisors increased its Charles River Laboratories (CRL) stake by 3.1% in Q2 2026, buying an estimated $13.4K and bringing the position to 2,499 shares worth $567K. The position accounts for 0.03% of the portfolio, ranked #388.

Aaron Wealth Advisors first reported a position in CRL in Q1 2022 and has held it in 6 quarters since. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Aaron Wealth Advisors held 2,499 shares of Charles River Laboratories worth $567K as of Q2 2026.
  • Aaron Wealth Advisors bought 75 Charles River Laboratories shares in Q2 2026, an estimated $13.4K.
  • Charles River Laboratories made up 0.03% of Aaron Wealth Advisors's portfolio in Q2 2026, its #388 holding.
  • Aaron Wealth Advisors first reported a position in Charles River Laboratories in Q1 2022 and has held it in 6 quarters since.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.